valganciclovir teva 450 mg tabletki powlekane
teva pharmaceuticals polska sp. z o.o. - valganciclovirum - tabletki powlekane - 450 mg
entecavir fomed 0,5 mg tabletki powlekane
fomed pharmaceuticals sl - entecavirum monohydricum - tabletki powlekane - 0,5 mg
entecavir fomed 1 mg tabletki powlekane
fomed pharmaceuticals sl - entecavirum monohydricum - tabletki powlekane - 1 mg
vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - dyslipidemie - Środki modyfikujące poziom lipidów - indicated to reduce cardiovascular risk as an adjunct to statin therapy.
abiraterone mylan
mylan ireland limited - octan abirateronu - nowotwory stercza - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
sugammadex mylan
mylan ireland limited - sugammadex sodium - blokada nerwowo-mięśniowa - wszystkie inne produkty terapeutyczne - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
axura
merz pharmaceuticals gmbh - chlorowodorek memantyny - choroba alzheimera - inne leki przeciw otępieniu - leczenie pacjentów z umiarkowaną lub ciężką chorobą alzheimera.
circadin
rad neurim pharmaceuticals eec sarl - melatonina - zaburzenia inicjacji snu i utrzymania - psycholeptyki - circadin jest wskazany jako monoterapia do krótkotrwałego leczenia bezsenności pierwotnej, charakteryzującej się niską jakością snu u pacjentów w wieku 55 lat lub starszych.
firmagon
ferring pharmaceuticals a/s - degareliks - nowotwory stercza - terapia endokrynologiczna - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
memantine merz
merz pharmaceuticals gmbh - chlorowodorek memantyny - choroba alzheimera - inne leki przeciw otępieniu - leczenie pacjentów z umiarkowaną lub ciężką chorobą alzheimera.